Main products of Wuhan Zhonglian Pharmaceutical Group Co., Ltd.

After 60 years of development, the company has become a modern pharmaceutical enterprise combining traditional Chinese and western medicine, with an annual output of 65.438+0.6 billion tablets, 6 million bottles of syrup, more than 200 tons of granules, 65.438+0.2 billion capsules, 300 million soft capsules and 65.438+0.6 billion packets of powder. It is the first pharmaceutical enterprise in Hubei Province to pass GMP certification as a whole, and has been awarded the license by the Hubei provincial government.

The company has 32 registered varieties of Chinese and western medicines1piece, including 4 exclusive products1piece, 6 national protected varieties of traditional Chinese medicine and 3 patented products. The company's product development focuses on cardiovascular and cerebrovascular drugs, gynecological drugs, liver drugs, respiratory drugs and so on. At present, the company has formed a series of cardiovascular and cerebrovascular drugs represented by Maijun 'an Tablet and Xinnaoqing Soft Capsule, a series of gynecological drugs represented by Jiawei Biochemical Granule and 3D Mould Suppository, a series of liver drugs represented by Biejiajian Pill, and a series of respiratory drugs represented by Jinye Baidu Granule, Biyan Tablet and Li Qiang Ganmao Tablet.